User:Mr. Ibrahem/Cefepime

Cefepime, sold under the brand name Renapime among others, is an antibiotic used to treat intra abdominal infections, respiratory tract infections, skin and skin structure infections, urinary tract infections, meningitis, endocarditis, and sepsis. It works against both gram positive and gram negative bacteria. It is given by injection into a vein or muscle.

Common side effects include diarrhea, nausea, rash, and pain at the site of injection. Other side effects may include allergic reactions, Clostridioides difficile infection, and encephalopathy. There is no evidence of harm in pregnancy but such use has not been well studied. It is a fourth-generation cephalosporin.

Cefepime was patented in 1982 and approved for medical use in 1994. It is available as a generic medication. In the United Kingdom 10 doses of 2 grams costs the NHS about £110 as of 2021. This amount in the United States is about 70 USD. It was removed from the World Health Organization's List of Essential Medicines in 2019.